IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY - ANVISA Registration 80134860316
Access comprehensive regulatory information for IMMUNOHEMATOLOGY - RARE SERA FOR CONVENTIONAL METHODOLOGY in Brazil's medical device market through Pure Global AI's free database. This Risk Class III medical device is registered under ANVISA number 80134860316 and manufactured by MEDION DIAGNOSTICS GRIFOLS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until Jun 30, 2035.
This page provides complete technical specifications for 2 related devices, regulatory compliance details, 5 companies making the same product including MEDION GRIFOLS DIAGNOSTICS AG, MEDION DIAGNOSTICS GRIFOLS AG, and 5 recent registrations in the same technical category. Pure Global AI offers free access to over 100,000+ Brazilian medical device registrations, helping global MedTech companies navigate ANVISA regulations, identify competitors, and discover partnership opportunities efficiently.
Related Devices (2)
Registration Details
80134860316
25351457914202475
02513899000171
Company Information
Dates and Status
Jun 30, 2025
30/06/2035
09/18/2025 19:00:01
IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Anti-Lua for DG Gel
Not specified
80134860271
Dec 02, 2019
IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Anti-Lua for DG Gel
MEDION GRIFOLS DIAGNOSTICS AG
80134860271
Dec 02, 2019
IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Anti-Lub Mono-Type Dual
Not specified
80134860270
Nov 25, 2019
IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Anti-Lub Mono-Type Dual
MEDION GRIFOLS DIAGNOSTICS AG
80134860270
Nov 25, 2019
IMUNOHEMATOLOGIA - SOROS RAROS PARA METODOLOGIA CONVENCIONAL
Anti-M Mono-Type Dual e Anti-N (LN3/MN879) Mono-Type
Not specified
80134860264
Sep 02, 2019

